Cancer Statistics - Karmanos Cancer Institute

Cote ML, Kardia SLR, Wenzlaff AS, Ruckdeschel J, Schwartz AG. Racial
differences in familial aggregation of lung cancer in first degree relatives
of early onset lung cancer cases. JAMA 293:3036-3042, 2005.
De Roos AJ, Hartge P, Lubin J, Colt JS, Davis S, Cerhan JR, Severson
RK, Cozen W, Patterson DG, Needham LL, Rothman N. Persistent
organochlorine chemicals in plasma and risk of non-Hodgkin lymphoma.
Cancer Res 65:11214-11226, 2005.
Divine KK, Pulling LC, Marron-Terada PG, Liechty KC, Kang T, Schwartz
AG, Bocklage TJ, Coons TA, Gilliland FD, Belinsky SA. Multiplicity of
abnormal promoter methylation in lung adenocarcinomas from smokers
and never smokers. Int J Cancer 114: 400-405, 2005.
Engels EA, Cerhan JR, Linet MS, Cozen W, Colt JS, Davis S, Gridley
G, Severson RK, Hartge P. Immune-related conditions and immunemodulating
medications as risk factors for non-Hodgkin lymphoma:
a case-control study. Am J Epidemiol 162:1153-1161, 2005.
Engels EA, Chen J, Hartge P, Cerhan JR, Davis S, Severson RK, Cozen W,
Viscidi RP. Antibody responses to simian virus 40 T antigen: a casecontrol
study of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers
Prev 14:521-524, 2005.
Engels EA, Rollison DE, Hartge P, Baris D, Cerhan JR, Severson RK,
Cozen W, Davis S, Biggar RJ, Goedert JJ, Viscidi RP. Antibodies to JC and
BK viruses among persons with non-Hodgkin lymphoma. Int J Cancer
117:1013-1019, 2005.
Fu JB, Kau TY, Severson RK, Kalemkerian GP. Lung cancer in women:
analysis of the national Surveillance, Epidemiology and End Results
database. Chest 127:768-777, 2005.
Hartge P, Colt JS, Severson RK, Cerhan JR, Cozen W, Camann D, Zahm SH,
Davis S. Residential Herbicide Use and Risk of Non-Hodgkin Lymphoma.
Cancer Epidemiol Biomarkers Prev 14:934-937, 2005.
Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, Deapen D,
Lakhani I, Morrow M. Patterns and correlates of local therapy for women
with ductal carcinoma in situ. J Clin Oncol 23: 3001-7, 2005.
Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, Deapen D,
Salem B, Lakhani I, Morrow M. Surgeon perspectives about local therapy
for breast cancer. Cancer 104: 1854-61, 2005.
Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, Salem B,
Lakhani I, Morrow M. Patient involvement in surgery treatment
decisions for breast cancer. Journal of Clin Onc 23:5526-33, 2005.
Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, Lakhani I, Salem B,
Katz SJ. Satisfaction with surgery outcomes and the decision process in
a population-based sample of women with breast cancer. Health Services
Research 40(3):745-68, 2005.
Morrow M, Mujahid M, Lantz PM, Janz NK, Fagerlin A, Schwartz K,
Liu L, Deapen D, Salem B, Lahkani I, Katz SJ. Correlates of breast
reconstruction: results from a population-based study. Cancer
104:2340-6, 2005.
Morton LM, Hartge P, Holford TR, Holly EA, Chiu BCH, Vineis P, Stagnaro
E, Willett EV, Franceschi S, La Vecchia C, Hughes AM, Cozen W, Davis
S, Severson RK, Bernstein L, Mayne ST, Dee FR, Cerhan JR, Zheng T.
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis
from the InterLymph consortium. Cancer Epidemiol Biomarkers Prev
14:925-933, 2005.
Morton LM, Zheng T, Holford TR, Holly EA, Chiu BCH, Costantini AS,
Stagnaro E, Willett EV, Maso LD, Serraino D, Chang ET, Cozen W,
Davis S, Severson RK, Bernstein L, Mayne ST, Dee FR, Cerhan JR,
Hartge P. Alcohol consumption and risk of non-Hodgkin lymphoma:
a pooled analysis from the InterLymph consortium. Lancet Oncol
6:469-476, 2005.
Patel DA, Barnholtz-Sloan JS, Patel MK, Malone JM Jr, Chuba PJ, Schwartz
K. A survival advantage for Hispanic women with invasive cervical cancer:
Analysis of Surveillance, Epidemiology, and End Results Data. Gynecol
Oncol 97: 550-8, 2005.
Patel DA, Bock CH, Schwartz K, Wenzlaff AS, Demers RY, Severson RK.
Sexually Transmitted Diseases and Other Urogenital Conditions as Risk
Factors for Prostate Cancer: A Case-Control Study in Wayne County,
Michigan. Cancer Causes and Control 16: 263-273, 2005.
Patel DA, Knowles A, Schwartz AG, Schwartz K. Evaluation of African
American and white racial classification in a Surveillance, Epidemiology
and End Results cancer registry. Ethnicity & Disease, 15:713-19, 2005.
Schwartz AG. Genetic Susceptibility to Lung Cancer. In: Lung Cancer:
Principles and Practice, 3rd Edition. HI Pass, JB Mitchell, D Johnson,
A Turissi, J Minna (Eds). JB Lippincott, Philadelphia, PA. 2005.
Schwartz AG. The Changing Face of Lung Cancer, pp628-632. American
Society of Clinical Oncology Education Book. Perry MC (Ed). 2005 ASCO.
Alexandria, VA.
Schwartz AG, Prysak GM, Murphy V, Lonardo F, Pass H, Schwartz J,
Brooks S. Nuclear estrogen receptor β in lung cancer: expression and
survival differences by sex. Clinical Cancer Research 11:7280-7, 2005.
Simon MS, Korczak JF, Yee CL, Schwartz AG. Racial Differences in the
Familial Aggregation of Breast Cancer and Other Female Cancers.
Breast Cancer Research and Treatment 89:227-235, 2005.
Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR,
Schwartz AG. CYP1A1 and CYP1B1 polymorphisms and risk of lung
cancer among never smokers: a population-based study. Carcinogenesis
26: 2207-2212, 2005.
Wenzlaff AS, Cote ML, Bock CH, Land SJ, Schwartz AG. GSTM1, GSTT1
and GSTP1 polymorphisms, environmental tobacco smoke exposure
and risk of lung cancer among never smokers: a population-based study.
Carcinogenesis 26: 395-401, 2005.
29